HLA-BAT1 alters migration, invasion and pro-inflammatory cytokines in prostate cancer.

Saved in:

Bibliographic Details
Title:	HLA-BAT1 alters migration, invasion and pro-inflammatory cytokines in prostate cancer.
Authors:	García-Vargas AM; Department of Pharmacology and Toxicology, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States., Roque-Reyes YM; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Department of Biology, University of Puerto Rico, Rio Piedras Campus, San Juan, PR, United States., Arroyo-Villegas DM; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Department of Chemistry, University of Puerto Rico, Rio Piedras Campus, San Juan, PR, United States., Santiago-Negron D; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University, Nashville, TN, United States., Sánchez-Vázquez MM; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States., Rivera-Torres A; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Department of Chemistry, University of Puerto Rico, Rio Piedras Campus, San Juan, PR, United States., Reyes-Meléndez AC; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Department of Biology, University of Puerto Rico, Rio Piedras Campus, San Juan, PR, United States., Cardona-Berdecía V; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Department of Chemistry, University of Puerto Rico, Rio Piedras Campus, San Juan, PR, United States., García-Maldonado M; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States., Víquez OM; Research Biobank, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States., Martínez-Ferrer M; Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University, Nashville, TN, United States.
Source:	Frontiers in oncology [Front Oncol] 2022 Nov 23; Vol. 12, pp. 969396. Date of Electronic Publication: 2022 Nov 23 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2234-943X
DOI:	10.3389/fonc.2022.969396